# Fixed Dose Combination of Desloratadine / Prednisolone in the Treatment of Moderate Severe Allergic Rhinitis in Children

> **NCT05214911** · PHASE3 · COMPLETED · sponsor: **Eurofarma Laboratorios S.A.** · enrollment: 262 (actual)

## Conditions studied

- Allergic Rhinitis

## Interventions

- **DRUG:** Desloratadine , Prednisolone
- **DRUG:** Desloratadine

## Key facts

- **NCT ID:** NCT05214911
- **Lead sponsor:** Eurofarma Laboratorios S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-08
- **Primary completion:** 2025-03-23
- **Final completion:** 2025-03-23
- **Target enrollment:** 262 (ACTUAL)
- **Last updated:** 2025-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05214911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05214911, "Fixed Dose Combination of Desloratadine / Prednisolone in the Treatment of Moderate Severe Allergic Rhinitis in Children". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05214911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*